Pathalys Pharma Alternatives & Competitors
12 companies similar to Pathalys Pharma — Our mission is to improve the lives of patients through enhanced therapeutics to...
Walden Biosciences
Transforming the Treatment of Kidney Disease
Cambridge, United States
Nephrogen
Curative gene therapies for kidney diseases
New York, United States
Purespring Therapeutics
We are Purespring. We are on a mission to radically transform the treatment of kidney dis...
London, United Kingdom
Corstasis Therapeutics
Advancing Options for Patients Suffering from Edema Associated with Congestive Heart Failu...
Henderson, United States
Track all Pathalys Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Helex
Genomic medicines for kidney diseases with high unmet need
New York, United States
Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...
La Jolla, United States
Mironid® Limited
Mobkoi specializes in premium mobile marketing using rich media, video, and display to rea...
Glasgow, United Kingdom
Interrupt Biomedical and Engineering Inc.
health technologies for everyone
Istanbul, Turkey
Vironix Health
Comprehensive AI-Virtual Care Management: Clinically-Validated, AI-Health Risk Prevention
Austin, United States
Heartseed Inc.
Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...
Japan
Charco
Charco is a medtech start-up working on a system for people with Parkinson's to improve th...
Cambridge, United Kingdom
Kyverna Therapeutics
Harnessing the power of cell therapy in autoimmune disease.
Emeryville, United States
About Pathalys Pharma
Our mission is to improve the lives of patients through enhanced therapeutics to advance the management of CKD.
Development of therapeutics for chronic kidney disease, Innovative drug solutions for secondary hyperparathyroidism, Late-stage clinical trials for kidney disease treatments, Regulatory submission and approval process navigation
Patients with chronic kidney disease, Patients undergoing hemodialysis, Healthcare providers specializing in nephrology, Medical research organizations
Biopharmaceutical, Late-stage Clinical Development, Chronic Kidney Disease, End-stage Renal Disease, Secondary Hyperparathyroidism, Therapeutics Development, Unmet Medical Needs, Patient-centric, Pharmaceutical Innovation, Catalys Pacific Partnership, DaVita Collaboration, Parathyroid Disorders, Hyperparathyroidism Treatment, Multi-asset Pharmaceutical
B2B, B2D
Product Sales, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Pathalys Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Pathalys Pharma on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 20 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.